4 Topic Commentaries

FDA Approves New Treatment for Thyroid Eye Disease

• 

  Andrea Lora Kossler, MD

  Ophthalmology (Oculoplastic and Orbital Surgery)

  •

  Stanford University School of Medicine (Byers Eye Institute)

  We did not expect such a dramatic improvement, especially after just two infusions.

  Source
• 

  Nicholas Mahoney, MD

  Ophthalmology (Oculoplastic and Orbital Surgery)

  •

  Johns Hopkins Medicine, Wilmer Eye Institute

  We’ve never had a medicine that’s been able to do that in the past.

  Source
• 

  Roger Dailey, MD, FACS

  Ophthalmology (Oculoplastic and Orbital Surgery)

  •

  Oregon Health & Science University, Casey Eye Institute

  Having a drug that reduces the disfiguring signs and visually disturbing symptoms can absolutely dramatically improve a patient’s quality of life.

  Source
• 

  David Toro Tobon, MD

  Endocrinology

  •

  Mayo Clinic, Rochester, Minnesota

  Except for certain approved targeted therapies for TED, the vast majority of these novel agents remain investigational and are currently undergoing rigorous clinical trial evaluation.

  Source